Hemolytic anemia in COVID-19
COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with …
coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with …
Drugs for COVID-19: An update
J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine …
Abstract Background Coronavirus SARS-CoV-2, the causative agent of COVID-19, has
caused a still evolving global pandemic. Given the worldwide vaccination campaign, the …
caused a still evolving global pandemic. Given the worldwide vaccination campaign, the …
Kinase inhibitors as potential therapeutic agents in the treatment of COVID-19
Corona virus is quickly spreading around the world. The goal of viral management is to
disrupt the virus's life cycle, minimize lung damage, and alleviate severe symptoms …
disrupt the virus's life cycle, minimize lung damage, and alleviate severe symptoms …
The role of cyclodextrins in COVID-19 therapy—a literature review
B Almeida, C Domingues, F Mascarenhas-Melo… - International Journal of …, 2023 - mdpi.com
Coronavirus disease-19 (COVID-19) emerged in December 2019 and quickly spread, giving
rise to a pandemic crisis. Therefore, it triggered tireless efforts to identify the mechanisms of …
rise to a pandemic crisis. Therefore, it triggered tireless efforts to identify the mechanisms of …
The immunology of SARS-CoV-2 infection and vaccines in solid organ transplant recipients
D Dęborska-Materkowska, D Kamińska - Viruses, 2021 - mdpi.com
Since its outbreak in December 2019, the coronavirus disease 2019 (COVID-19) pandemic,
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an …
A review on drug repurposing in COVID-19: From antiviral drugs to herbal alternatives
A Sezer, M Halilović-Alihodžić, AR Vanwieren… - Journal of Genetic …, 2022 - Springer
Background COVID-19 is an illness caused by severe acute respiratory syndrome
coronavirus 2. Due to its rapid spread, in March 2020 the World Health Organization (WHO) …
coronavirus 2. Due to its rapid spread, in March 2020 the World Health Organization (WHO) …
Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approaches
Steam inhalation therapy can be a contemporary approach for COVID-19 affected patients of
all age groups to manage respiratory conditions, though it presently lacks the scientific …
all age groups to manage respiratory conditions, though it presently lacks the scientific …
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study
MJ Nino-Orrego… - … Advances in Drug …, 2022 - journals.sagepub.com
Background: The COVID-19 pandemic has led to an increase in the behavior of self-
medication (SM). Given the massive release of misleading information during the pandemic …
medication (SM). Given the massive release of misleading information during the pandemic …
An overview of repurposed drugs for potential COVID-19 treatment
K Govender, A Chuturgoon - Antibiotics, 2022 - mdpi.com
The COVID-19 pandemic caused by SARS-CoV-2 has placed severe constraints on
healthcare systems around the globe. The SARS-CoV-2 virus has caused upheaval in the …
healthcare systems around the globe. The SARS-CoV-2 virus has caused upheaval in the …